Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Bowel cancer screening eligibility now 45

Bowel Cancer Australia 2 mins read

Bowel cancer screening eligibility now 45

People aged 45-49 now eligible to request a free screening test as announced in 2024-25 Federal Budget

 

  • Over 1.6 million Australians aged 45-49 are now eligible to participate in the National Bowel Cancer Screening Program (NBCSP) on an opt-in basis.
  • Since 2018, Bowel Cancer Australia has advocated for screening from age 45.
  • People aged 40-49 account for 56% of new cases and 64% of deaths in those diagnosed under 50.

 

Wednesday 15 May, Sydney: Bowel Cancer Australia has welcomed another milestone in its 6-year campaign, with the Australian Government lowering eligibility for bowel cancer screening from age 50 to 45, as announced in the Federal Budget.

 

From 1 July 2024, an additional 1.6 million Australians aged 45-49 will be eligible to request a screening test from the National Bowel Cancer Screening Program. Once a person aged 45-49 opts-in to the Program, they will receive a screening test every two years.

 

Over the past three decades, bowel cancer rates have been increasing in people under age 50, both in Australia and globally.

 

1,716 Australians are diagnosed with early-onset bowel cancer each year, with people aged 40-49 accounting for 56 percent of new cases and 64 percent of deaths in those diagnosed under 50.

 

Bowel Cancer Australia CEO Julien Wiggins said: “We have been advocating tirelessly for the lowering of the screening age in response to the increasing rates of bowel cancer in younger people.”

 

We thank our dedicated and passionate advocates for their ongoing support of our campaign, along with members of the recently established Parliamentary Friends of Bowel Cancer.”

 

The Budget announcement follows updated clinical practice guidelines recommending a lowering of the bowel cancer screening start age which were endorsed by the National Health and Medical Research Council (NHMRC) in October 2023.

 

The updated clinical practice guidelines also recommend people aged 40-44 can request screening via their healthcare professional prior to receiving their first NBCSP invitation.


Contact details:


For an interview with a medical expert or patient contact:
Stephanie Bansemer-Brown – Bowel Cancer Australia
[email protected]   |   0412 915 797

Media

More from this category

  • Indigenous, Medical Health Aged Care
  • 18/03/2026
  • 07:21
Australian and New Zealand Journal of Public Health / Public Health Association of Australia

Emerging Aboriginal leaders call for greater Indigenous control over native foods

As Australia’s native food industry booms, experts say Indigenous people must have a seat at the table Aboriginal leaders and advocates have joined together today to call out commercial companies exploiting native food knowledge without adequate community engagement. They are urging government action to ensure Indigenous people can better lead and control the access and benefits that arise from their traditional foods and knowledge. The new evidence-based commentary, published in the Australian and New Zealand Journal of Public Health, represents the collective view of six leading Aboriginal academics and one non-Indigenous researcher with expertise across bush food, traditional Indigenous medicines,…

  • Medical Health Aged Care
  • 18/03/2026
  • 01:41
DNA Script

DNA Script Expands Global Access to On-demand DNA Synthesis With Distributor Agreements in Latin America and East Asia

Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hours Establishes direct distribution networks across Latin America, Japan and South Korea PARIS–BUSINESS WIRE– DNA…

  • Contains:
  • Medical Health Aged Care
  • 18/03/2026
  • 01:21
Vectramind Health

Healthcare Technology Research Company, KLAS Research, Reports 100% of Surveyed Customers Would Buy Vectramind Health’s Firstpass Platform Again

Dubai, UAE— March 2026Vectramind Health today announced that its’ AI-native patient experience and engagement platform, Firstpass, has received strong validation in a newly released KLAS First Look report highlighting high levels of customer satisfaction and measurable improvements in patient engagement and operational efficiency. The findings, published in theKLAS Research report‘Vectramind Firstpass Unified Patient Experience & Engagement Platform 2026’, show that100% of surveyed customers said they would buy Firstpass again and consider the platform part of their long-term plans.Healthcare organizations also reported increased patient engagement, improved patient flow, reduced no-show rates, and reduced waiting times. The KLAS Research findings, which are…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.